G43.9 G40
Conditions
Interventions
Group 1: Patients with migraine and epilepsy
The analysis includes about 300 patients who were treated for epilepsy and suffered from migraine at the same time in the period 2010-2022. The following
Sponsors
Klinikum Großhadern, LMU München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients with migraine (chronic or episodic) and epilepsy. - Age = 18
Exclusion criteria
Exclusion criteria: - Secondary headache (tumor-related, traumatic brain injury) - Age < 18 - Lack of ability to adequately describe the complaints - Lack of written consent or lack of ability to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary: Analysis of the number of intensity & headache days per month during the course of epilepsies. Duration of studies The study duration is 5 years. Patients will be interviewed prospectively by telephone/at the scheduled follow-up about headache days, headache intensity, medication and other complaints. A standardized questionnaire is used for this purpose. The individual interview takes about 15 minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary: semiology of headache, course of headache with respect to established and newer anticonvulsant medications, seizure frequency, epilepsy syndrome. | — |
Countries
Germany
Contacts
Public ContactCem Thunstedt
Neurologie
Outcome results
None listed